Credent Connect N Care
add_icon

Credent Connect N Care IPO

IPO Open Now
₹2,14,800
Bidding Dates 13 Aug, 26 -17 Aug, 26
Min Investment ₹2,14,800
Lot Size600
Price Range ₹179 – ₹189
Issue Size ₹93.90 Cr.
Download Doc
IPO Timeline
IPO Offer Start
13 Aug,26
IPO Offer Ends
17 Aug,26
Allotment Finalisation
18 Aug,26
Refund Initiation
19 Aug,26
Listing of Shares
20 Aug,26

IPO Analysis

Strengths
Strenghts

The company operates a comprehensive healthcare ecosystem catering to hospitals, clinics, diagnostic laboratories, IVD companies, and pharmaceutical companies. The company focuses on time-sensitive and compliance critical logistics, supported by cold chain enabled network and multimodal transportation including road, air, and onboard courier services with trained workforce across multiple cities.

Strenghts

The company has a client base providing repeated business with revenue generated from around 280 domestic customers including 38 customers who have associated with the company for the last three continuous years. The company maintains healthy relationships through regular communication and flexible logistics solutions ensuring samples reach destinations on time and in optimal condition.

Strenghts

The company's promoters, Chairman and Managing Director Tarun Sharma and Whole Time Director & Chief Financial Officer Karan Sharma have over 12 years and 9 years of experience each in the logistics industry. Their expertise lies in strategic planning, team management, business development, business strategy, sales management and competitive analysis.

Risks
Risk

The company derives a significant portion of revenue from its top 10 customers (81.76% in Fiscal 2026) without firm commitments. The loss of any major customers could materially affect business operations and financial performance.

Risk

The company's business is dependent on diagnostic and healthcare companies' testing volumes and outsourcing requirements. Any reduction in testing volumes or adverse sector developments could materially affect business and results of operations.

Risk

The company is exposed to risks of loss, damage, contamination or delay in transportation of diagnostic samples. Such incidents could result in client claims, financial liabilities and reputational harm affecting business operations.

Objectives

The company proposes to invest in Credent Healthcare Private Limited to meet its working capital requirements, primarily for trade receivables and funding day-to-day operations.

The company plans to invest in Credent Healthcare Private Limited to finance capital expenditure for procuring sonography machines and digital X-ray machines for diagnostic services.

The company proposes to utilize funds towards funding long-term working capital requirements for executing increased order volumes, high inventory levels, high debtors, and advance payments to suppliers.

The company intends to repay in part or full certain borrowings availed from lenders to reduce outstanding indebtedness and debt servicing costs.

The company will utilize funds for general corporate purposes including meeting operating expenses, initial development costs, strengthening business development and marketing capabilities, and meeting exigencies.

Yearly Financial Results

Annual Financials
Mar 2026
Revenue
214.16
Expenses
189.83
Other Income
0.27
Total Revenue
214.43
Profit Before Tax
24.59
Net Profit
18.45

Balance Sheet

Balance Sheet
Mar 2026
Total Assets
81.57
Current Assets
63.05
Fixed Assets
18.52
Total Equity & Liabilities
81.57
Total Liabilities
37.78
Current Liabilities
30.63
Non Current Liabilities
7.15
Total Equity
43.79

Cash Flow

Cash Flow
Mar 2026
Net Cash Flow
1.25
Investing Activities
-10.78
Operating Activities
-6.62
Financing Activities
18.66

About Credent Connect N Care

The company is a healthcare services provider engaged in delivering integrated logistics, workforce solutions, and technology-enabled support to healthcare institutions across India. The company provides comprehensive operational and logistics services to diagnostic laboratories, In Vitro Diagnostics (IVD) companies, pharmaceutical companies, clinics, and other healthcare enterprises through end-to-end solutions. The company's...more
Managing DirectorTarun Sharma